Blood & Cancer

Anticoagulation in cancer


 

In this episode, Alok Khorana, MD, of the Cleveland Clinic, joins David H. Henry, MD, to discuss results from the CASSINI trial and what it means for anticoagulation in cancer patients.
And Ilana Yurkiewicz, MD, begins part 1 of her look at informed consent. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford (Calif.) University and is also a columnist for Hematology News. More from Dr. Yurkiewicz here.
Subscribe to Blood & Cancer here:
Apple Podcasts

Google Podcasts

Recommended Reading

CDC Expands Assessment Study of Toxic Chemicals Near Military Bases
Federal Practitioner
Histoplasmosis Manifests After Decades
Federal Practitioner
Don’t forget social determinants of health in minority MS patients
Federal Practitioner
Eczema increases the risk of impaired mental health among children
Federal Practitioner
ASCO issues guideline for early detection, management of colorectal cancer
Federal Practitioner
New SOFA version could streamline outcomes research
Federal Practitioner
FDA approves intranasal esketamine for refractory major depressive disorder
Federal Practitioner
Positive FIT test should prompt new colonoscopy
Federal Practitioner
Women survive more often than men do when hospitalized with cirrhosis
Federal Practitioner
Lentiviral gene therapy appears effective in X-CGD
Federal Practitioner